| 2281 |
CINNARIZINE |
CINNARIZINE 25 MG |
TABLET |
BOTTLE |
FOR THE SYMPTOMATIC TREATMENT OF NAUSEA AND VERTIGO DUE TO MENIERE'S DISEASE AND OTHER LABYRINTHINE DISTURBANCES, PREVENTION AND TREATMENT OF MOTION SICKNESS AND PERIPHERAL VASCULAR INSUFFICIENCY SUCH AS ARTERIOSCLEROSIS IN ELDERLY PATIENTS |
NULL |
SOKDY OSOTH IMPORT-EXPORT CO., LTD |
UTOPAIN CO.,LTD |
THAILAND |
CERTIFICATE RELEASED |
04 I 3543/11 |
18-AUG-2023 |
17-AUG-2026 |
View |
| 2282 |
CIPROFLOXACIN |
CIPROFLOXACIN BP 200 MG/100 ML |
SOLUTION FOR INJECTION |
BOTTLE |
TREATMENT OF RESPIRATORY TRACT INFECTION, URINARY TRACT INFECTION, SKIN AND SOFT TISSUE INFECTION, BONE AND JOINT INFECTION, GYNAECOLOGICAL INFECTION, SURGICAL INFECTION |
NULL |
SOKDY OSOTH IMPORT-EXPORT CO., LTD |
SHIJIAZHUANG NO.4 PHARMACEUTICAL CO.,LTD |
CHINA |
CERTIFICATE RELEASED |
09 I 4563/18 |
22-APR-2025 |
21-APR-2030 |
View |
| 2283 |
CLARID |
LORATADINE 10 MG |
TABLET |
ALU-PVC BLISTER |
USED TO TREAT SNEEZING, RUNNY NOSE, EYE IRRITATION CAUSED BY ALLERGY SYMPTOMS, ALSO USED TO TREAT SKIN HIVES AND SKIN ALLERGY |
NULL |
SOKDY OSOTH IMPORT-EXPORT CO., LTD |
BIOLAB CO.,LTD |
THAILAND |
CERTIFICATE RELEASED |
12 I 5154/21 |
25-OCT-2024 |
24-OCT-2029 |
View |
| 2284 |
CLOXACILLIN SODIUM FOR INJECTION 1 G |
CLOXACILLIN SODIUM EQ.TO CLOXACILLIN 1 G |
POWDER FOR SOLUTION FOR INJECTION |
VIAL |
TREATMENT OF SKIN AND SOFT TISSUES INFECTIONS, BONE AND JOINT INFECTIONS, RESPIRATORY INFECTIONS INCLUDING PNEUMONIA, SEPTICEMIC INFECTION INCLUDING ENDOCARDITIS |
NULL |
SOKDY OSOTH IMPORT-EXPORT CO., LTD |
REYOUNG PHARMACEUTICAL CO., LTD |
CHINA |
CERTIFICATE RELEASED |
03 I 4360/18 |
22-APR-2025 |
21-APR-2030 |
View |
| 2285 |
CLOXIN |
CLOXACILLIN SODIUM 136.25 MG EQ.TO CLOXACILLIN BASE 125 MG |
POWDER FOR ORAL SUSPENSION |
BOTTLE |
TREATMENT OF SUSCEPTIBLE BACTERIAL INFECTIONS, NOTABLY PENICILLINASE-PRODUCING STAPHYLOCOCCI CAUSING RESPIRATORY TRACT, SKIN AND SKIN STRUCTURE, BONE AND JOINT, URINARY TRACT INFECTIONS |
NULL |
SOKDY OSOTH IMPORT-EXPORT CO., LTD |
UTOPAIN CO.,LTD |
THAILAND |
CERTIFICATE RELEASED |
06 I 3152/08 |
18-AUG-2023 |
17-AUG-2026 |
View |
| 2286 |
VAPTOR TABLETS 10 MG |
ROSUVASTATIN (AS CALCIUM) 10 MG |
FILM-COATED TABLETS |
ALU-ALU |
TREATMENT OF HYPERCHOLESTEROLEMIA AND PREVENTION OF CARDIOVASCULAR EVENTS |
NULL |
POUNSAB PHARMA CO.,LTD |
THE SEARLE COMPANY LIMITED |
PAKISTAN |
STEP 1: RECEIVE (RENEW) |
04 I 4390/18 |
03-AUG-2022 |
02-AUG-2025 |
View |
| 2287 |
VAPTOR TABLETS 20 MG |
ROSUVASTATIN (AS CALCIUM) 20 MG |
FILM-COATED TABLETS |
ALU-ALU |
TREATMENT OF HYPERCHOLESTEROLEMIA AND PREVENTION OF CARDIOVASCULAR EVENTS |
NULL |
POUNSAB PHARMA CO.,LTD |
THE SEARLE COMPANY LIMITED |
PAKISTAN |
STEP 1: RECEIVE (RENEW) |
04 I 4391/18 |
03-AUG-2022 |
02-AUG-2025 |
View |
| 2288 |
VAPTOR TABLETS 5 MG |
ROSUVASTATIN(AS CALCIUM) 5 MG |
FILM-COATED TABLETS |
ALU-ALU |
TREATMENT OF HYPERCHOLESTEROLAEMIA AND PREVENTION OF CARDIOVASCULAR EVENTS |
NULL |
POUNSAB PHARMA CO.,LTD |
THE SEARLE COMPANY LIMITED |
PAKISTAN |
STEP 1: RECEIVE (RENEW) |
04 I 4389/18 |
03-AUG-2022 |
02-AUG-2025 |
View |
| 2289 |
VENTEK TABLETS 10 MG |
MONTELUKAST SODIUM 10.4 MG EQ.TO MONTELUKAST 10 MG |
FILM-COATED TABLETS |
ALU-ALU |
FOR PROPHYLAXIS AND CHRONIC TREATMENT OF ASTHMA, INCLUDING THE PREVENTION OF DAY AND NIGHT TIME SYMPTOMS, THE TREATMENT OF ASPIRIN SENSITIVE ASTHMATIC PATIENTS, AND PREVENTION OF EXCERCISE INDUCED BRONCHOCONSTRICTION. FOR THE RELIEF OF SYMPTOMS OF SEASONAL ALLERGIC RHINITIS IN ADULTS AND PEDIATRIC PATIENTS. |
NULL |
POUNSAB PHARMA CO.,LTD |
THE SEARLE COMPANY LIMITED |
PAKISTAN |
STEP 1: RECEIVE (RENEW) |
04 I 4393/18 |
03-AUG-2022 |
02-AUG-2025 |
View |
| 2290 |
VENTEK TABLETS 4 MG |
MONTELUKAST SODIUM 4.16 MG EQ.TO MONTELUKAST 4 MG |
CHEWABLE TABLET |
ALU-ALU |
FOR PROPHYLAXIS AND CHRONIC TREATMENT OF ASTHMA, INCLUDING THE PREVENTION OF DAY AND NIGHT TIME SYMPTOMS, THE TREATMENT OF ASPIRIN SENSITIVE ASTHMATIC PATIENTS, AND PREVENTION OF EXCERCISE INDUCED BRONCHOCONSTRICTION. FOR THE RELIEF OF SYMPTOMS OF SEASONAL ALLERGIC RHINITIS IN ADULTS AND PEDIATRIC PATIENTS. |
NULL |
POUNSAB PHARMA CO.,LTD |
THE SEARLE COMPANY LIMITED |
PAKISTAN |
STEP 1: RECEIVE (RENEW) |
04 I 4394/18 |
03-AUG-2022 |
02-AUG-2025 |
View |
